# Damora Therapeutics, Inc. (DMRA): MoatMap facts

As of 14 Oct 2026. Research data, not investment advice.

As of 14 Oct 2026, MoatMap's StockRank for Damora Therapeutics, Inc. (DMRA) is 12/100, ranked against 24,000+ stocks in 35 markets (Quality 35, Value 27, Momentum 25, each scored against its sector).

- StockRank: 12/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 35, Value 27, Momentum 25: each a 0-100 percentile within the stock's sector.
- Position: #23,736 overall, #2,221 in Healthcare.
- Listing: United States, NCM; Healthcare / Biotechnology.
- Last close: 20.255 USD on 12 Oct 2026.
- Insider filings, last 180 days: directors bought USD 253K; directors sold USD 7K.

Source: https://moatmap.ai/stock/DMRA
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker